Vive Le Canada

Is This Drug Company Taking Advantage of Canada?
Date: Thursday, October 17 2013

 You don't have to be on drugs to make sense of Eli Lilly's $500-million NAFTA lawsuit against Canada but, as the saying goes, it would probably help. The case is astoundingly dangerous with global consequences. It should trigger an immediate review of the investment "rights" chapter in NAFTA as well as other trade and investment deals signed or under negotiation by the federal government.

read full article

This article comes from Vive Le Canada

The URL for this story is: